Please ensure Javascript is enabled for purposes of website accessibility

Why General Electric Stock Dropped 1.6% Today

By Rich Smith – Updated Apr 13, 2020 at 4:18PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company is juggling financial obligations to make its way through the recession.

What happened

Shares of General Electric (GE -1.31%) bounced around today, initially falling more than 5% in the morning before ending the day down 1.68%.

So what

At last report, GE was carrying a bit more than $94 billion in net debt, and had only about $14.5 billion in cash on hand with which to service it. Last month, however, the company received permission from the Federal Trade Commission to proceed with its sale of its BioPharma business to Danaher (DHR -1.47%) for about $21 billion.

This sale has now closed. And today, General Electric CEO Larry Culp announced:

[W]ith net proceeds of about $20 billion from the sale of BioPharma now in hand, we are taking swift actions to de-risk and de-lever our balance sheet and prudently manage our liquidity amid a challenging external environment. We continue to execute on our priorities, including solidifying our financial position by further reducing debt and improving our cash operations and management. We remain committed to achieving our leverage goals over time. 


Chalboard drawing of arrow going down labeled down

Image source: Getty Images.

The company plans to use part of the proceeds from the GE BioPharma sale to pay off about $9 billion worth of debt, and will also issue new debt with which to buy back and pay off certain bonds issued by its industrial subsidiaries. Although these bond buybacks will not decrease the total amount of money owed, GE says it does hope to extend the period for maturity of much of its debt by replacing old bonds with new ones.  

Now what

Were GE to spend the entire proceeds of its GE BioPharma sale on paying back debt, and all of its cash on hand as well, the company would still end up with a debt load of nearly $60 billion. That's quite a burden to be carrying into the teeth of a global pandemic and global recession. Nevertheless, the company's ability to use the cash it has available to juggle its debt around and postpone when debt comes due means it has a better chance of waiting out the recession, and paying off its obligations once the business environment improves.

Net-net, that seems a positive in my book. Investors who sold off GE stock early in the day may have missed this point. With GE still generating $3 billion annually in free cash flow (not counting whatever damage the coronavirus is now wreaking), and the debt picture now looking more manageable, GE looks like a better bet to me today than it did as recently as Friday.

Rich Smith has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

General Electric Company Stock Quote
General Electric Company
$61.91 (-1.31%) $0.82
Danaher Corporation Stock Quote
Danaher Corporation
$258.29 (-1.47%) $-3.86

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/01/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.